The company said it received 170 reports of hyperglycemia and 11 reports of diabetic ketoacidosis in the U.S. that could be linked to the problem.

Galway: Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed 600 series or 700 series insulin pumps to follow their pump's

Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life.

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the issue has revealed that the devices may experience shortened battery life if they are dropped,

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump.

Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages.

Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.